Nano Drug Crosses Blood-Brain Tumor Barrier toTarget Tumor Cells, Ohio State University Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC